NCT06184438View on ClinicalTrials.gov

Randomized Control Trial of Micronized Purified Flavonoid Fraction for Post Operative Treatment in Anal Fistula Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

December 13, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

March 31, 2025

Conditions
Anal Fistula
Interventions
DRUG

Micronized purified flavonoid fraction(Daflon 1000mg)

Received Micronized purified flavonoid fraction(Daflon 1000mg) BID after surgery from day to day 7

DRUG

Placebo

Received placebo after surgery.

Trial Locations (1)

235

Taipei Medical University Shuang-Ho Hospital, New Taipei City

All Listed Sponsors
lead

Taipei Medical University Shuang Ho Hospital

OTHER

NCT06184438 - Randomized Control Trial of Micronized Purified Flavonoid Fraction for Post Operative Treatment in Anal Fistula Surgery | Biotech Hunter | Biotech Hunter